US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist

17.450
-0.220-1.25%

Close Feb 28 16:00 ET

17.450
0.0000.00%

Post 16:16 ET

255.57MMarket Cap-2.63P/E (TTM)

Anika Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Anika Therapeutics Q4 2024 Estimates Date

Currency：USDMar 12, 2025

	Estimate	YoY
Revenue	29.00M	-32.51%
EPS	-0.29	+93.14%

Analyst Rating

No Data

Anika Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 28.125M	--
Mar 12, 2025	2024/Q4	-- / 29.000M	--
Oct 31, 2024	2024/Q3	38.753M / 42.083M	--
Aug 8, 2024	2024/Q2	41.921M / 40.766M	--
May 8, 2024	2024/Q1	40.523M / 39.143M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 28.125M--

Mar 12, 20252024/Q4-- / 29.000M--

Oct 31, 20242024/Q338.753M / 42.083M--

Aug 8, 20242024/Q241.921M / 40.766M--

May 8, 20242024/Q140.523M / 39.143M--

Unlock Free Earnings Estimates

Open Account

Anika Therapeutics Earnings Reports

Anika Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 4, 2024 16:44 ET

Anika Therapeutics | 8-K: Anika Reports Third Quarter 2024 Financial Results

Oct 31, 2024 07:25 ET

Anika Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 17:24 ET

Anika Therapeutics | 8-K: Anika Reports Second Quarter 2024 Financial Results

Aug 8, 2024 16:19 ET